Navigation Links
Toward making 'extended blood group typing' more widely available
Date:7/14/2010

Scientists are reporting an advance toward enabling more blood banks to adopt so-called "extended blood group typing," which increases transfusion safety by better matching donors and recipients. Their report on a new, automated genetic method for determining a broader range of blood types appears in ACS' Analytical Chemistry, a semi-monthly journal.

Christophe Marquette and colleagues explain that most blood banks still use a century-old blood approach to blood typing. It identifies blood group antigens on red blood cells -- proteins that must match in donor and recipient to avoid potentially serious transfusion reactions. Most blood currently is typed for only a few of the 29 known human blood groups, even though some rare blood groups can affect the outcome of a transfusion. Commercial technology does exist for extended typing with DNA tests. However, it is expensive, difficult to use, and suited more for research labs than high-volume blood centers, they state. Wide adoption of extended blood group typing, they note, requires a test that can handle the high volume of blood processed each year -- 14 million donations in the United States, for instance, and 20 million in Europe.

The study describes evaluation of the new more affordable method, called the HiFi Blood 96, which types blood with DNA testing in a high-speed automated procedure. Tests on 293 human blood samples demonstrated the performance and reliability of the new method. The report compares HiFi Blood 96 to existing commercial tests, and discusses improvements that are underway.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert  

Page: 1

Related biology news :

1. Scientists locate oil plume extending toward Dry Tortugas
2. International panel recommends redirecting the world community toward sustainable growth
3. Scientists make important step toward stopping plaque-like formations in Huntingtons disease
4. New steps toward a universal flu vaccine
5. Toward simplifying treatment of a serious eye infection
6. Toward a urine test for detecting colon cancer
7. Congress takes another stride toward public access to research
8. Metabolic fingerprints offer fresh clues and a new path toward personalized medicine
9. Toward safer plastics that lock in potentially harmful plasticizers
10. An electrifying advance toward tomorrows power suits
11. Discovery points toward anti-inflammation treatment for blinding disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Toward making 'extended blood group typing' more widely available
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017  Neogen Corporation (NASDAQ: ... terminated its agreement with SenesTech Incorporated (NASDAQ: ... a rodenticide being developed by SenesTech. The two firms ... time when the SenesTech product was approved by the ... approval provided that the product could only be used ...
(Date:1/24/2017)... and DURHAM, N.C. , ... IRB in customer service and technology, announces that ... the organization as Biosafety Officer. In ... leadership to develop and manage a forthcoming institutional biosafety ... for research organizations navigating the IBC landscape. The new ...
(Date:1/24/2017)... 2017  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... medicine, today announced positive efficacy results from the ... showed additional motor function improvement at 6-months and ... in AIS-A patients with complete cervical spinal cord ... motor function is critically important to patients with ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... waist circumference, and increased serum leptin levels had a positive association with increased ... The study published in the International Neurourology Journal involved 571 Korean men ...
Breaking Biology Technology: